Q2 2018 13F Holders as of 6/30/2018
-
Type / Class
-
Equity / Class B Common Stock
-
Shares outstanding
-
5.07M
-
Number of holders
-
316
-
Total 13F shares, excl. options
-
19.1M
-
Shares change
-
-74.9K
-
Total reported value, excl. options
-
$5.51B
-
Value change
-
-$8.92M
-
Put/Call ratio
-
0.94
-
Number of buys
-
144
-
Number of sells
-
-151
-
Price
-
$288.54
Significant Holders of BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) as of Q2 2018
349 filings reported holding BIO - BIO-RAD LABORATORIES, INC. - Class B Common Stock as of Q2 2018.
BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) has 316 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 19.1M shares
.
Largest 10 shareholders include BlackRock Inc. (1.86M shares), VANGUARD GROUP INC (1.8M shares), ATLANTA CAPITAL MANAGEMENT CO L L C (1.46M shares), ACADIAN ASSET MANAGEMENT LLC (748K shares), WELLS FARGO & COMPANY/MN (718K shares), AMERICAN CENTURY COMPANIES INC (692K shares), MILLENNIUM MANAGEMENT LLC (570K shares), TimesSquare Capital Management, LLC (548K shares), STATE STREET CORP (507K shares), and BANK OF AMERICA CORP /DE/ (334K shares).
This table shows the top 316 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.